spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 17 January 2006
doi: 10.1242/jcs.02744

Journal of Cell Science 119, 470-481 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Summary Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.02744v1
119/3/470    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gartsbein, M.
Right arrow Articles by Tennenbaum, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gartsbein, M.
Right arrow Articles by Tennenbaum, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

The role of protein kinase C {delta} activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation

Marina Gartsbein1, Addy Alt1, Koji Hashimoto2, Koichi Nakajima3, Toshio Kuroki4 and Tamar Tennenbaum1,*

1 Faculty of Life Sciences, Bar Ilan University, Ramat-Gan, 52900 Israel
2 Department of Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime 791-0295, Japan
3 Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka 545-8585, Japan
4 Gifu University, Yanagido 1-1, Gifu 501-1193, Japan

* Author for correspondence (e-mail: tennet{at}mail.biu.ac.il)

Accepted 3 October 2005


   Summary
Top
 Summary
Introduction
 Results
 Discussion
 Materials and Methods
 References
 
Activation of the STAT family of transcription factors is regulated by cytokines and growth factors. STAT tyrosine and serine phosphorylation are linked to the transcriptional activation and function of STAT. We have previously described a unique pathway inducing keratinocyte proliferation, which is mediated by insulin stimulation and depends on protein kinase C {delta} (PKC{delta}). In this study, we assessed STAT3 activation downstream of this pathway and characterized the role of PKC{delta} activation in STAT3 tyrosine and serine phosphorylation and keratinocyte proliferation. Following insulin stimulation, STAT3 interacted with PKC{delta} but not with any other PKC isoform expressed in skin. Activated forms of PKC{delta} and STAT3 were essential for insulin-induced PKC{delta}-STAT3 activation in keratinocyte proliferation. Abrogation of PKC{delta} activity inhibited insulin-induced STAT3 phosphorylation, PKC{delta}-STAT3 association and nuclear translocation. In addition, overexpression of STAT3 tyrosine mutant eliminated insulin-induced PKC{delta} activation and keratinocyte proliferation. Finally, overexpression of a STAT3 serine mutant abrogated insulin-induced STAT3 serine phosphorylation and STAT3-induced keratinocyte proliferation, whereas STAT3 tyrosine phosphorylation was induced and nuclear localization remained intact. This study indicates that PKC{delta} activation is a primary regulator of STAT3 serine phosphorylation and that PKC{delta} is essential in directing insulin-induced signaling in keratinocyte proliferation.

Key words: STAT3, PKC{delta}, Tyrosine phosphorylation, Serine phosphorylation, Keratinocyte, Proliferation


   Introduction
Top
 Summary
 Introduction
Results
 Discussion
 Materials and Methods
 References
 
STATs (signal transducers and activators of transcription) are cytoplasmic proteins that function as transcriptional activators. Seven STAT family members have now been identified including: STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6 (Akira, 1999Go; Akira, 2000Go; Horvath, 2000Go; Levy and Darnell, 2002Go). The use of isoform-specific transgenic knockout mouse models defined discreet physiological roles for each of the STAT family members. Among the seven known STAT proteins, STAT3 is unique. Only the STAT3-null phenotype in mice results in an embryonic-lethal phenotype at day 6-7 of fetal development, which cannot be compensated by any of the other STAT species expressed within the visceral endoderm (Akira, 1999Go). Furthermore, the importance of STAT3 for specific organ development was confirmed by experiments in which STAT3 expression was conditionally ablated in defined organs (Bromberg and Darnell, 2000Go; Sano et al., 2000Go; Takeda et al., 1997Go; Wen and Darnell, 1997Go). STAT3 has a specialized role in skin development. In the absence of STAT3 expression, both skin remodeling and hair cycle progression are severely disrupted (Sano et al., 1999Go; Sano et al., 2000Go).

The activation of STAT proteins involves tyrosine phosphorylation, dimerization, nuclear translocation and activation of transcription by binding to DNA-response elements of target genes (Bromberg and Darnell, 2000Go; Levy and Darnell, 2002Go). The STAT proteins are distinctive among transcription factors in containing an SH2 (Src-homology 2), phosphotyrosine-binding domain. The SH2 domain interacts with sites of tyrosine phosphorylation to recruit the STATs to receptor complexes. Each of the STATs is differentially activated by various extracellular ligands including growth factors, cytokines and hormones, allowing differential intracellular processing of transcriptional signals (Bromberg and Darnell, 2000Go). During activation, STAT proteins can be specifically phosphorylated on both tyrosine and serine residues. Tyrosine phosphorylation of STAT3 at a single tyrosine residue (Tyr705) located at the Src-homology domain is essential for the activation of STAT3 (Bromberg et al., 1998Go). Similarly, a single serine site (Ser727) located in a conserved Pro-X-Ser-Pro sequence was shown to regulate STAT3-mediated transcriptional activation (Bromberg et al., 1998Go; Decker and Kovarik, 2000Go; Lim and Cao, 1999Go; Turkson et al., 1999Go). However, although STAT serine phosphorylation was shown to be induced by several factors including interferon, epidermal growth factor and IL-6, its exact role in regulation of the STAT3 activation state has not been fully determined (Heim, 1999Go; Takeda et al., 1998Go; Zhang et al., 2000Go). In skin, the growth and differentiation of keratinocytes was shown to be regulated by many growth factors and cytokines including EGF family members, keratinocyte growth factor (KGF), TGF-ß, insulin, insulin-like growth factor-1 (IGF-1), PDGF, HGF, IL-6, IL-1 and TNF-{alpha} (Chen et al., 1995Go; Marchese et al., 1990Go; Shen et al., 2001Go; Wertheimer et al., 2001Go; Zendegui et al., 1988Go). Interestingly, in skin, as in other cellular model systems, STAT3 is activated by several of these growth factors including the EGF family of proteins, HGF, PDGF and insulin, as well as by cytokines of the interleukin family such as IL-6 and IL-11 (Hashimoto, 2000Go; Heinrich et al., 1998Go; Senaldi et al., 1999Go; Werner and Smola, 2001Go).

The protein kinase C (PKC) family of serine-threonine kinases plays an important regulatory role in a variety of biological phenomena (Dekker and Parker, 1994Go; Toker, 1998Go). The family is composed of at least 11 individual isoforms. In skin, protein kinase C (PKC) signaling was shown to be a major intracellular mediator of proliferation and differentiation pathways (Denning et al., 1996Go; Dotto, 1998Go; Matsui et al., 1992Go; Ohba et al., 1998Go). Utilizing both pharmacological activators of PKC as well as genetic approaches, we and others identified distinct roles for specific PKC isoforms in the induction of keratinocyte proliferation and differentiation in vivo and in vitro (Alt et al., 2001Go; Dlugosz et al., 1992Go; Dotto, 1998Go; Verma, 1988Go). Specifically, we previously showed that growth factors such as insulin-like growth factor-1 (IGF-1) and insulin, although similar in their structure, diverge in their downstream signaling to mediate skin keratinocyte proliferation. Furthermore, insulin-induced proliferation is uniquely mediated by activation of PKC{delta} (Jain et al., 1999Go; Novotny-Diermayr et al., 2002Go; Shen et al., 2001Go). In this study we demonstrate STAT3 activation and serine phosphorylation downstream of insulin-induced PKC{delta} activation and keratinocyte proliferation. However, although PKC{delta} activation is indispensable for insulin action in keratinocytes proliferation, eliminating STAT3 serine phosphorylation does not abrogate insulin-mediated PKC{delta} activation and keratinocyte proliferation.


   Results
Top
 Summary
 Introduction
 Results
Discussion
 Materials and Methods
 References
 
The role of STAT3 in signaling of keratinocyte proliferation
In previous studies, we identified a unique pathway involved in mediating insulin action in keratinocytes. This pathway uses the activation of PKC{delta} as a crucial signaling factor downstream of insulin to induce keratinocyte proliferation. One of the factors involved downstream of PKC{delta} signaling and which is affected by various cytokines and growth factors, is STAT3 (Boulton et al., 1995Go; Jain et al., 1999Go). To determine whether insulin signaling in keratinocytes may mediate its effects via STAT3 activation, we first examined the ability of insulin to regulate the phosphorylation state of STAT3 in these cells. As early as 5 minutes following insulin stimulation, tyrosine phosphorylation of STAT3 was induced; phosphorylation peaked by 15 minutes following stimulation (Fig. 1A). The phosphorylation of STAT3 was accompanied by its nuclear translocation, as observed by immunofluorescence (Fig. 1B).


Figure 1
View larger version (35K):
[in this window]
[in a new window]
  		Fig. 1. Insulin induces STAT3 activation and nuclear translocation in mouse primary keratinocytes. (A) Keratinocytes following 5 days in culture were stimulated with 10–7 M insulin for the times indicated. STAT3 immunoprecipitates were probed with anti-p-tyr-STAT3 (top panel). Equal loading of gels was confirmed by reblotting with STAT3 antibody (bottom panel). Relative optical density of four representative blots is presented in arbitrary units (mean ± s.d.). (B) Keratinocytes were plated on glass slides. Cultures (5 days old) were stimulated with insulin for 5 minutes, fixed in ethanol and analyzed by immunofluorescence, using anti-p-tyr-STAT3, followed by FITC-conjugated secondary antibody. Cells were viewed by confocal microscopy. (C) Keratinocytes were stimulated with 10–7 M insulin for the times indicated. STAT3 immunoprecipitates were probed with anti-IRß antibody (top panel) and with anti-IGF 1Rß antibody (middle panel). Equal loading of gels was confirmed by reblotting with STAT3 antibody (bottom panel). The experiment was repeated twice. Bar, 20 µm.

 
Specificity of STAT3 activation to the insulin-signaling pathway was further corroborated by following STAT3 association with the insulin receptor. As early as 2 minutes following insulin stimulation, activated STAT3 was physically associated with the insulin receptor (Fig. 1C). Moreover, insulin did not induce association of STAT3 with the insulin-like growth factor-1 (IGF-1) receptor, suggesting that the specificity of insulin-induced STAT3 activation to insulin receptor mediated signaling (Fig. 1C).


Figure 2
View larger version (23K):
[in this window]
[in a new window]
  		Fig. 2. Protein kinase C {delta} (PKC{delta}) specifically associates with STAT3. Keratinocytes (5 day cultures) were infected with isoform-specific PKC {alpha}, {delta}, {eta} and {zeta} recombinant adenoviruses, or with adenovirus encoding ß-galactosidase (ß-Gal) as a control, for 1 hour. OE, overexpression. Following infection, cells were incubated for 24 hours, then extracted and immunoprecipitated (IP) with antibodies against PKC{alpha}, PKC{delta}, PKC{eta} and PKC{zeta}. Immunoprecipitates were subjected to western blot analysis using isoform-specific anti-PKCs or anti-STAT3 antibodies. Results presented are representative of at least three experiments.

 
Effects of insulin on the PKC{delta}-STAT3 complex
Our previous studies identified PKC{delta} as a primary mediator of insulin signaling in keratinocyte proliferation. Since PKC{delta} activation was previously linked to STAT3 signaling, we next investigated whether the PKC{delta} isoform could physically bind to STAT3. Using recombinant PKC adenoviruses, keratinocytes were transduced with recombinant PKC adenoviruses where ß-gal-infected keratinocytes were used as controls for the viral infection (Miyake et al., 1996Go; Ohba et al., 1998Go). Lysates were subjected to immunoprecipitation with antibodies to PKC isoforms expressed in skin including: PKCs {alpha}, {delta}, {zeta} and {eta}, and immunoprecipitates were then subjected to western blot analysis using a STAT3-specific antibody. The overexpression of various PKC isoforms effectively induced protein expression five- to tenfold above basal levels associated with constitutive activation of the PKCs isoforms (Fig. 2) (Alt et al., 2004Go). Under unstimulated basal conditions, STAT3 was associated with PKC{delta} but not with PKC isoforms {alpha}, {zeta} or {eta}, expressed in skin (Fig. 2).


Figure 3
View larger version (38K):
[in this window]
[in a new window]
  		Fig. 3. Insulin-induced PKC{delta} activation regulates STAT3 association and phosphorylation. (A) Keratinocytes were untreated (–) or treated with insulin for 5 minutes (+). PKC{delta} immunoprecipitates were subjected to western blot analysis using antibodies against STAT3, anti-phosphotyrosine-705-STAT3 (p-tyr), anti-phosphoserine-727-STAT3 (p-ser) and anti-PKC{delta}. Relative optical densities of the blots are presented in arbitrary units. Relative optical density of four blots is presented in arbitrary units (mean ± s.d.). (B) Primary keratinocytes were either untreated or infected for 1 hour with isoform-specific PKC recombinant adenovirus, or with ß-galactosidase (ß-Gal) adenovirus as control. Control cells were either untreated (C) or stimulated with insulin for 5 minutes (Ins 5'). Cells were extracted and immunoprecipitated (IP) with isoform-specific PKC antibodies. The immunoprecipitates were subjected to western blot analysis using anti-PKCs, anti-STAT3 or anti-phosphoserine-727-STAT3 (STAT p-ser) antibodies. Experiments were repeated three times.

 
Furthermore, as can be seen in Fig. 3A, following stimulation by insulin, a dramatic increase of STAT3 serine phosphorylation was observed within the complex. Tyrosine phosphorylation was also increased, indicating STAT3 activation. However, no induction in STAT3 tyrosine or serine phosphorylation was observed in PKC immunoprecipitates of insulin-stimulated keratinocytes and keratinocytes overexpressing PKC isoforms {alpha}, {zeta} or {eta} (Fig. 3B and results not shown). Although PKC-overexpressing keratinocytes expressed similar levels of each of the PKC isoforms, constitutive association and phosphorylation of STAT3 was evident only with PKC{delta} (Fig. 2).

A direct link between PKC{delta} activity and complex formation and activation was next confirmed by abrogation of PKC{delta} activity. Overexpression of a kinase inactive PKC{delta} form (dominant-negative PKC) reduced STAT3-PKC{delta} complex formation (Fig. 4A,B) and decreased both tyrosine and serine phosphorylation of STAT3 following insulin stimulation (Fig. 4B,C). Similar results were obtained when we inhibited PKC{delta} activity using the PKC{delta} inhibitor, rottlerin (results not shown). Collectively, these results confirm the link between insulin-induced PKC{delta} activation and the STAT3 phosphorylation state.


Figure 4
View larger version (35K):
[in this window]
[in a new window]
  		Fig. 4. Insulin-induced PKC{delta}-STAT3 association and activation depends on PKC{delta} activity. (A) Keratinocytes were infected (OE) for 1 hour with recombinant ß-Gal (control), wild-type (WT) PKC{delta} and dominant-negative PKC{delta} (DN PKC{delta}) adenovirus constructs. Following infection, cells were incubated for 18 hours, and left untreated (–) or stimulated with insulin for 5 and 30 minutes. STAT3 immunoprecipitates were subjected to western blot analysis and probed with anti-PKC{delta} and anti-STAT3 antibodies. (B) Keratinocytes were either infected for 1 hour with ß-Gal or WT STAT3 adenovirus constructs, or double infected with DN PKC{delta} followed by WT STAT3 recombinant adenovirus infection. Following infection, cells were incubated for 24 hours and overexpressing cells were untreated (–) or stimulated with insulin for 5 and 30 minutes. PKC{delta} immunoprecipitates were subjected to western blot analysis and probed with anti-phosphoserine-727-STAT3 (STAT3-p-ser), anti-PKC{delta} and anti-STAT3 antibodies. (C) Keratinocytes were either uninfected (–) or infected (OE) for 1 hour with recombinant dominant-negative PKC{delta} (DN PKC{delta}) adenovirus. After 24 hours, cells were left untreated (–) or treated with insulin for 5 minutes. PKC{delta} immunoprecipitates were subjected to western blot analysis and probed with anti-phosphotyrosine-705-STAT3 (STAT3-p-tyr) and anti-PKC{delta} antibodies. Relative optical density of three blots are presented in arbitrary units (mean ± s.d.). Experiments were repeated at least three times.

 

PKC{delta}-STAT3 association also depends on the activation of STAT3
Using a STAT3 wild-type construct and a dominant-negative STAT3 mutant (STAT3-705-tyrosine mutant), efficient expression of STAT3 could be achieved in keratinocytes, at levels 5- to 20-fold above basal expression (Fig. 5A). As expected, overexpressed wild-type STAT3 was constitutively phosphorylated on tyrosine residues and was found complexed with PKC{delta}. Similarly to the endogenous protein, insulin stimulation for 5 minutes further increased tyrosine phosphorylation of the overexpressed STAT3 (Fig. 5B). The importance of tyrosine residue 705 to the insulin-induced activation of STAT3 was further verified using a STAT3 tyrosine mutant in which Tyr705 was exchanged with phenylalanine. Following overexpression of the dominant-negative STAT3 tyrosine (705) mutant, insulin could no longer induce STAT3 tyrosine phosphorylation (Fig. 5B). This confirmed STAT3 Tyr705 to be essential for STAT3 activation by insulin (Fig. 5B). PKC{delta} and wild-type STAT3 were physically associated, and stimulation with insulin further augmented this association (Fig. 5C). Interestingly, overexpression of the tyrosine-inactive STAT3 mutant did not abrogate constitutive PKC{delta}-STAT3 complex formation. However, insulin-induced association was abolished, suggesting that STAT3 activation is not a prerequisite for complex formation with PKC{delta}. Similarly to the endogenous STAT3 protein, in keratinocytes overexpressing wild-type STAT3, inhibition of PKC{delta} activity by overexpression of a dominant-negative PKC{delta} decreased STAT3 tyrosine phosphorylation as well as its association with PKC{delta} (Fig. 5D). Similar results to those obtained by overexpressing a dominant-negative form of PKC{delta} were obtained using rottlerin, a specific inhibitor of PKC{delta} activation (results not shown). However, the STAT3 activation state also contributed to insulin-induced activation of PKC{delta}, as demonstrated in PKC activity assays. As early as 5 minutes following insulin stimulation, PKC{delta} activity was increased in PKC{delta} immunoprecipitates (Fig. 6A) and PKC activity was found to reside within STAT3 immunoprecipitates (Fig. 6B). Furthermore, dominant-negative STAT3-inhibited insulin-induced activation of endogenous and overexpressed PKC{delta} (Fig. 6A,B). Overall, these results suggest that the active form of PKC{delta} is required for the formation of the insulin-induced STAT3-PKC{delta} complex, and emphasize the crosstalk between PKC{delta} and STAT3 in regulating the activation state of the PKC{delta}-STAT3 complex.


Figure 5
View larger version (21K):
[in this window]
[in a new window]
  		Fig. 5. Overexpression of WT STAT3 and DN STAT3 using recombinant adenoviruses. (A,B,C) Primary keratinocytes were infected for 1 hour using ß-galactosidase (ß-Gal), WT STAT3 and DN STAT3 recombinant adenoviruses containing a hemagglutinin (HA) tag, and experiments were conducted 24 hours after infection. (A) Total cell lysates were subjected to western blot analysis using anti-STAT3 antibody. (B) Overexpressing cells were either untreated (–) or treated with insulin for 5, 15 and 30 minutes. Lysates were immunoprecipitated with anti-HA antibody and immunoprecipitates analyzed by western blotting, using a anti-p-tyr-STAT3 antibody. (C) Overexpressing cells were treated with insulin for 5 and 30 minutes. PKC{delta} immunoprecipitates were analyzed by western blotting, using anti-HA and anti-STAT3 antibodies. Equal loading of gels was confirmed by reblotting with PKC{delta} antibody. Relative optical density of three representative blots is presented in arbitrary units (mean ± s.d.). (D) Keratinocytes were either infected (OE) for 1 hour with WT STAT3 adenovirus constructs or double infected with DN PKC{delta} followed by WT STAT3 recombinant adenovirus infection. 24 hours following infection, cells were untreated (–) or treated with insulin for 5 minutes. HA immunoprecipitates were subjected to western blot analysis and probed with anti-phosphotyrosine and anti-HA antibodies. Experiments were repeated at least three times.

 

Figure 6
View larger version (14K):
[in this window]
[in a new window]
  		Fig. 6. DN STAT3 blocks insulin-induced PKC{delta} activation. Keratinocytes were either uninfected (–), or infected with DN STAT3 adenovirus. Following infection (24 hours), cells were untreated, or stimulated with 10–7 M insulin (Ins) for the designated times (5 or 30 minutes). (A) PKC{delta} or (B) STAT3 were immunoprecipitated from protein extracts using specific anti-PKC{delta} and anti-STAT3 antibodies. PKC{delta} and STAT3 immunoprecipitates were analyzed for PKC activity using an in vitro kinase assay as described in Materials and Methods. Each bar represents the mean ± s.d. of three determinations in three separate experiments. Values are expressed as picomoles of ATP per dish per minute. Highly significant differences were found (P<0.0001) for both IP PKC{delta} and STAT3 compared with levels in the respective controls at 5 minutes.

 
Nuclear translocation of STAT3
STAT3 activation is characterized by induction of tyrosine phosphorylation and dimerization of STAT3 followed by nuclear translocation of the STAT3 complex. Therefore, we next investigated the link between insulin-induced PKC{delta} activation and STAT3 nuclear translocation. In non-stimulated keratinocytes, no STAT3 was detected in the nucleus (Fig. 7A). However, as early as 5 minutes following insulin stimulation, tyrosine-phosphorylated STAT3 was observed in the nucleus, where the signal was retained for 15 minutes, and faded 30 minutes following stimulation. Pretreatment with rottlerin before insulin stimulation, completely inhibited translocation of STAT3 to the nucleus, but some tyrosine-phosphorylated STAT3 could be detected in the cytoplasm of insulin-stimulated cells (Fig. 7A, lower panel). Interestingly, following insulin stimulation, the nuclear translocation of STAT3 was not accompanied by nuclear translocation of PKC{delta}. Under basal conditions, PKC{delta} expression was detected mostly in the cytoplasm, whereas in some cells, a perinuclear distribution was noticed. Following insulin stimulation, PKC{delta} distribution was shifted to the perinuclear area including the nuclear membrane but no protein was seen within the nucleus (Fig. 7B). Inhibition of PKC{delta} activity by pretreatment with rottlerin prior to insulin stimulation, completely abolished redistribution of PKC{delta} expression following insulin stimulation (data not shown).


Figure 7
View larger version (67K):
[in this window]
[in a new window]
  		Fig. 7. Insulin-induced STAT3 nuclear translocation is abrogated by PKC{delta} inhibition. Primary keratinocytes were plated on glass slides and maintained for 5 days in low-Ca2+ MEM (0.05 mM) until they reached 80% confluence. (A) Cells were left untreated (upper panel) or pre-treated with 5 µM rottlerin (Rott) for 7 minutes (lower panel), followed by 10–7 M insulin for 5 and 30 minutes (Ins). Cells were fixed in methanol, washed and air-dried. Cultures were analyzed by immunofluorescence using anti-phospho-tyr-705-STAT3 (STAT3-p-tyr) antibody, followed by FITC-conjugated secondary antibody. Slides were viewed by confocal microscopy. (B) Cells were untreated (–) or treated with insulin (Ins) for 5 and 30 minutes. Following treatment, cells were fixed in methanol and analyzed by immunofluorescence using anti-PKC{delta} antibody followed by FITC conjugated secondary antibody and scanned by confocal microscope. Arrow in middle panel indicates translocation of PKC{delta} to the perinuclear membranes. Experiments were repeated at least three times. Bar, 20 µm.

 

Role of STAT3 serine phosphorylation
To directly study the functional contribution of STAT3 serine phosphorylation to insulin-induced PKC{delta} activation in keratinocyte proliferation, we next constructed a HA-tagged STAT3 Ser727 to Ala mutant. Ser727 located at the Pro-X-Ser-Pro motif was previously shown to contribute to transcriptional activation of STAT3 (Chung et al., 1997Go; Jain et al., 1999Go; Novotny-Diermayr et al., 2002Go). This mutant (SmS) was introduced into an adenovirus construct and used to follow the STAT3 activation state in response to insulin stimulation. STAT3 SmS was efficiently expressed in keratinocytes (Fig. 8). No serine phosphorylation was observed in the overexpressing keratinocytes, in either the basal state (Fig. 9B) nor in response to insulin stimulation (Fig. 8C), confirming that the Ser727 residue is uniquely phosphorylated in response to insulin. However, surprisingly, in the basal state, constitutive tyrosine phosphorylation of the serine mutant STAT3 was increased at least five- to tenfold above levels observed with wild-type STAT3 (Fig. 8B), and the STAT3 serine mutant was localized to the nucleus of unstimulated, overexpressing cells (results not shown). Furthermore, the STAT3 serine mutant was constitutively associated with PKC{delta}, but no further increase in STAT3 tyrosine phosphorylation and association with PKC{delta} was seen in response to insulin stimulation (Fig. 8C).


Figure 8
View larger version (21K):
[in this window]
[in a new window]
  		Fig. 8. Overexpression of serine mutant STAT3 using recombinant adenovirus. (A) Keratinocytes were infected for 1 hour using recombinant adenoviruses encoding ß-Gal and STAT3 serine mutant (SmS). After 18 hours, total cell lysates were subjected to western blot analysis utilizing anti-STAT3 (top panel), anti-STAT3-p-tyr (middle panel) and STAT3-p-ser (bottom panel) antibodies. (B,C) Keratinocytes were infected for 1 hour using recombinant adenoviruses encoding WT STAT3, DN STAT3 and STAT3 serine mutant (SmS). After 24 hours, cells were (B) left untreated or (C) stimulated with insulin for the designated time periods (0, 5, 15 or 30 minutes). HA immunoprecipitates were subjected to western blot analysis and probed with anti-STAT3-p-tyr (top panel), anti-STAT3-p-Ser (middle panel) and anti-STAT3 (bottom panel) antibodies. Relative optical density of three representative blots is presented in arbitrary units (mean ± s.d.). (D) Keratinocytes were infected for 1 hour using recombinant adenoviruses encoding WT STAT3 and STAT3 serine mutant (SmS). Cells were stimulated with insulin for 5 and 30 minutes. Lysates were immunoprecipitated with PKC{delta} antibody and analyzed by western blotting, using anti-HA. Equal loading of gels was confirmed by reblotting with PKC{delta} antibody. Relative optical density of blots is presented in arbitrary units (mean ± s.d.). Experiments were repeated at least three times.

 

Figure 9
View larger version (25K):
[in this window]
[in a new window]
  		Fig. 9. Effects of overexpression of PKC{delta} and STAT3 on keratinocytes proliferation and cell death. Keratinocytes were infected for 1 hour with (A) recombinant adenoviruses ß-Gal, PKC{delta}, WT STAT3, DN STAT3 or double infected with DN PKC{delta} followed by WT STAT3 or with DN STAT3 followed by WT PKC{delta} infection. (B) with recombinant adenoviruses ß-Gal, PKC{delta}, DN PKC{delta}, WT STAT3, DN STAT3 and STAT3 serine mutant (SmS) and un-treated (–) or treated (+) with insulin. Twenty-four hours following infection, cell proliferation was analyzed by [3H]thymidine incorporation as described in Materials and Methods. Results are presented as cpm/µg protein. Each bar represents the mean of three determinations in a plate from the same culture. Experiments were repeated at least three times. (mean ± s.d.). Significant differences were observed between ß-gal control values and those for WT STAT3 (P<0.001) and PKC{delta} (P<0.0005). (C) Keratinocytes were infected with recombinant adenoviruses encoding ß-Gal, PKC{delta}, WT STAT3, DN STAT3 and STAT3 serine mutant (SmS). Following infection (24 hours) FACS cell-cycle analysis of propidium-iodide-stained keratinocytes was performed. Apoptotic cell death was defined as the sub-G1 population (Apo, percentage of sub-G1 population) and proliferation was identified as the population of S-phase cells (S, percentage of S-phase population).

 
The role of STAT3 in keratinocyte proliferation
In previous studies, we identified a pathway which links PKC{delta} activation by insulin to keratinocyte proliferation (Shen et al., 2001Go). Therefore, we next studied the involvement of STAT3 in this pathway. Overexpression of PKC{delta} and overexpression of STAT3 were able to induce keratinocyte proliferation to a similar degree (Fig. 9A). No proliferation was induced when cells were infected with dominant-negative constructs of STAT3 and PKC{delta} as well as by overexpression of the STAT3 serine mutant (Fig. 9A, SmS). These results further confirmed that STAT3 serine phosphorylation is required for induction of keratinocyte proliferation. Moreover, abrogation of PKC{delta} activity by infection with a DN PKC{delta} construct inhibited proliferation induced by STAT3 overexpression (Fig. 9A). We next investigated the role of STAT3 serine and tyrosine phosphorylation and the activation state of PKC{delta}, in the regulation of insulin-induced keratinocyte proliferation. Following overexpression of WT STAT3, DN STAT3, SmS and kinase active (WT) and kinase inactive (DN) PKC{delta}, only inactivation of PKC{delta} significantly inhibited insulin-induced keratinocyte proliferation (Fig. 9B). These results suggest an imperative regulatory role for PKC{delta}, in mediating insulin signaling via the STAT3-PKC{delta} pathway in insulin-induced keratinocyte proliferation. However, STAT3 mutants were unable to abrogate insulin-induced keratinocyte proliferation suggesting a lesser role for STAT3 compared with PKC{delta} in the regulation of insulin action in keratinocytes,

The role of PKC{delta} and STAT3 in inducing keratinocyte proliferation was also confirmed by FACS analysis (Fig. 9C and results not shown). Increase in the percentage of actively proliferating S-phase cells was detected following overexpression with WT PKC{delta} and WT STAT3 recombinant adenoviruses whereas infection with DN PKC{delta}, DN STAT3 and SmS did not induce cell proliferation (Fig. 9C). Interestingly, by following the Sub-G1 population we identified that in comparison to ß-Gal overexpressing cells, only overexpression of WT PKC{delta} but not overexpression of DN PKC{delta}, WT STAT3 or STAT3 mutants induced keratinocyte apoptosis (Fig. 9C, A-apoptotic cells). Collectively, the results suggest that PKC{delta} plays a specific role in regulation of STAT3 727 serine phosphorylation and mediation of insulin-induced keratinocyte proliferation.


   Discussion
Top
 Summary
 Introduction
 Results
 Discussion
Materials and Methods
 References
 
The STAT family of proteins are transcriptional activators, which can be activated in response to a variety of stimuli including cytokines, growth factors and hormones (Calo et al., 2003Go; Heim, 1999Go). However, the mechanism of STAT activation is unique, compared with that of other transcriptional activators. The presence of an SH2 domain and a C-terminal tyrosine residue, which becomes phosphorylated upon stimulation, provides the basis for the interaction of STATs with several signaling complexes. Such signaling pathways can directly regulate subsequent homo- and heterodimerization of the protein to direct its localization to the nucleus. In the nucleus, STATs bind DNA to induce transcription of specific genes (Chatterjee-Kishore et al., 2000Go; Imada and Leonard, 2000Go; Levy and Darnell, 2002Go). In this study, we describe a unique pathway in skin keratinocyte proliferation, which involves STAT3 activation downstream of insulin-mediated PKC{delta} activation. The association between STAT3 serine phosphorylation and PKC{delta} was previously established in other STAT3-mediated pathways including stimulation with IL6, LIF and EGF (Jain et al., 1999Go; Novotny-Diermayr et al., 2002Go; Schuringa et al., 2001Go). In addition to PKC{delta}, several other kinases including Erk, p38, and JNK have been shown to directly or indirectly induce phosphorylation of STAT3-Ser727 (Abe et al., 2001bGo; Chung et al., 1997Go; Jain et al., 1998Go; Jain et al., 1999Go; Kuroki and O'Flaherty, 1999Go; Lim and Cao, 1999Go; Sengupta et al., 1998Go; Xu et al., 2003Go). However, the specific physiological role for this interaction was not determined. Our study establishes a direct link between STAT3 serine phosphorylation and the activation and regulation of keratinocyte proliferation in response to insulin signaling in the skin. Our previous studies suggested that the activation of PKC{delta} by insulin is unique and is not induced by other factors such as EGF, PDGF, IGF or KGF (Shen et al., 2001Go). This study extends these results to identify STAT3 activation and serine phosphorylation as downstream regulators of insulin-mediated signaling in keratinocyte proliferation. Moreover, the physical linkage between PKC{delta} and STAT3 was shown to be specific and does not involve other PKC isoforms expressed in the skin. Upon insulin-induced activation of PKC{delta}, STAT3 becomes phosphorylated on both serine and tyrosine residues, leading to subsequent STAT3 nuclear localization and activation. Abrogation of PKC{delta} activity was able to inhibit the physical association of STAT3 with PKC{delta} as well as to inhibit STAT3 phosphorylation, nuclear translocation and activation. Furthermore, abrogation of either PKC{delta} activity or serine phosphorylation of STAT3-blocked PKC{delta} and STAT3-mediated keratinocyte proliferation. However, although abrogation of PKC{delta} activity was able to inhibit STAT3-induced keratinocyte proliferation, a dominant-negative form of STAT3 was not able to efficiently inhibit PKC{delta}-induced proliferation. These results suggest that serine phosphorylation of STAT3 by PKC{delta} is indispensable for the downstream STAT3 signaling in mediation of keratinocyte proliferation. Furthermore, STAT3 mutants were not able to inhibit insulin-induced proliferation. These results could be associated with the inefficient physical link between PKC{delta} and STAT3 mutant forms (SmS and DN STAT3) allowing the activation of endogenous STAT3 by insulin-induced PKC{delta} activation. However, other possible explanations could be related to the STAT3 mechanism of action. STAT3 as a transcription activator acts downstream of various signaling pathways including signaling by IGF-1 and Leptin. The convergence of IGF-1 and Leptin pathways with the insulin signaling pathway can lead to indirect effects of insulin via alternative pathways following the blockade of insulin-STAT3 activation (Kim et al., 2000Go; Xu et al., 2005Go). Therefore, chronic effects of insulin on cell proliferation measured 18-24 hours following stimulation does not reflect directly just acute activation of PKC{delta} and STAT3 but rather is the consequence of the overall compensatory mechanisms. Finally, although our results clearly show that insulin does not phosphorylate STAT3 mutants, constitutive complex formation of STAT3 with PKC{delta} and nuclear localization of the STAT3 mutant protein suggest alternative mechanisms distinct from protein phosphorylation to transmit insulin signaling in cell proliferation. Although the role of tyrosine phosphorylation as an essential step for activation of STAT3 is well established (Darnell et al., 1994Go; Levy and Darnell, 2002Go), the precise role of a single serine phosphorylation event, such as the one associated with the activation of Ser727 in STAT3, was not known. Indeed, in several studies, serine phosphorylation was shown to coincide with and contribute to transcriptional activation following stimulation in vitro (Ceresa and Pessin, 1996Go; Decker and Kovarik, 2000Go; Gotoh et al., 1996Go). However, several recent studies suggested that STAT3 serine phosphorylation following stimulation with EGF, NGF or IL-6 has a regulatory role distinct from that of STAT tyrosine phosphorylation and activation (Abe et al., 2001aGo; Kovarik et al., 1999Go; Lim and Cao, 1999Go). In keratinocytes, tyrosine and serine phosphorylation of STAT3 seem to coincide following insulin stimulation. However, in cells expressing a STAT3 Ser727 mutation, serine phosphorylation was completely abrogated whereas STAT3 tyrosine phosphorylation was significantly increased. These results are in agreement with recent results obtained in transgenic mice expressing a form of the STAT3 Ser727 mutant (Shen et al., 2004Go). Although fibroblasts carrying the serine mutation are defective in their transcriptional response in vitro, fibroblasts induced by oncostatin M exhibit intact tyrosine phosphorylation of STAT3. Furthermore, in the serine-mutant mouse, many of the downstream signaling pathways associated with STAT3 remain intact (Shen et al., 2004Go). Interestingly, in the serine-mutant mouse, STAT3 serine phosphorylation was found to specifically affect levels of members of the insulin like growth factor (IGF1) family and to influence growth-hormone-mediated signaling. Furthermore, the phenotype observed with this mutant was associated with marked growth retardation, reduced thymic epithelial cell number and induction of apoptotic cell death (Shen et al., 2004Go). These results are in agreement with our study supporting a role for STAT3 activation and serine phosphorylation in the physiological proliferation of keratinocytes under the regulation of another member of the insulin family of growth factors, insulin. Overall, these results suggest that rather than transcription per se, serine phosphorylation is involved in directing the specificity of the signaling pathway. Indeed, serine phosphorylation could be associated with a variety of mechanisms regulating cell signaling leading to calibration of the signal and a specific physiological outcome. These mechanisms include the induction of conformational changes, induction of specific complex formation, and phosphorylation and regulation of other downstream effectors by PKC{delta} and STAT3. The unique ability of a transcription factor such as STAT3 to physically interact via an SH2 domain with various signaling protein complexes would also provide a mechanism whereby a downstream element such as STAT3 could affect PKC{delta} activation via phosphorylation or direct interaction with various components of the signaling complex.

The association of STAT3 with cell proliferation was established in several model systems. STAT3 was found to be activated and constitutively phosphorylated in many tumor cells in vitro and in vivo (Bromberg et al., 1999Go; Frank, 1999Go; Takeda et al., 1998Go; Turkson and Jove, 2000Go) including the induction of the oncogenic phenotype in Src-transformed fibroblasts (Bromberg et al., 1998Go; Silva, 2004Go; Turkson et al., 1998Go). In addition, specifically in skin, targeted deletion of STAT3 abrogates skin remodeling and is associated with a blockage of hair-cycle progression and impaired wound healing (Akira, 2000Go; Sano et al., 1999Go; Sano et al., 2000Go).

Interestingly, similarly to STAT3, PKC{delta} activation in several model systems was shown to mediate signaling by growth factors such as EGF, NGF, PDGF, insulin, TNF{alpha} and IL-6 (Gliki et al., 2001Go; Jackson et al., 2001Go; Jain et al., 1999Go; Kontny et al., 1999Go; Novotny-Diermayr et al., 2002Go; Robin et al., 2004Go; Shen et al., 2001Go). However, although STAT3 was shown to be involved in mediating cell growth and oncogenic potential, further studies suggest PKC{delta} to be primarily involved in cell differentiation and apoptosis; thus inhibition of PKC{delta} activity and loss of PKC{delta} during transformation are associated with cell growth and oncogenesis (Fujii et al., 2000Go; Li et al., 1999Go; Li et al., 1996bGo; Lucas and Sanchez-Margalet, 1995Go). Our results suggest possible explanations for the role of PKC{delta} in directing the specificity of signal activation in keratinocytes. Under physiological settings in normal primary keratinocytes, PKC{delta} activation is associated with STAT3 and linked to insulin signaling and keratinocyte proliferation. However, in cell transformation and during tumor progression, PKC{delta} expression is downregulated or inactivated (Geiges et al., 1995Go; Joseloff et al., 2002Go; Langzam et al., 2001Go). The resulting loss of STAT3-PKC{delta} complexes could contribute to the transformed phenotype by enabling STAT3 phosphorylation and activation to come under the regulation of a variety of other growth factors distinct from insulin (Bromberg et al., 1999Go; Calo et al., 2003Go; Chan et al., 2004Go). Alternatively, the fact that only PKC{delta} but not STAT3 overexpression could induce cell apoptosis suggests that PKC{delta}-mediated apoptosis is distinct from the proliferative pathway which is regulated by both PKC{delta} and STAT3 activation. Another possible explanation for the differences between PKC{delta} and STAT3 regulation could be based on intracellular localization. For example, our results in primary murine keratinocytes demonstrated PKC{delta} translocation to the perinuclear region following insulin stimulation to be independent of the nuclear translocation of STAT3. Furthermore, our study has confirmed that whereas serine phosphorylation is crucial for functional outcome, the serine mutation does not abrogate nuclear translocation. These results are in agreement with recent studies suggesting that the C-terminus trans-activating domain and not the N-terminal domain regulates STAT3 nuclear localization (Ma et al., 2003Go; Pranada et al., 2004Go). Therefore, although STAT3 serine phosphorylation is coupled to PKC{delta} translocation to the nucleus in a variety of transformed cell lines, the perinuclear localization of PKC{delta} in primary keratinocytes could result in a different physiological outcome in response to STAT3 phosphorylation and transactivation (Buchner, 2000Go; Goodnight et al., 1995Go; Jain et al., 1999Go). Overall, these results suggest a specific role for PKC{delta} as a serine kinase of STAT3 and as a regulator of insulin-mediated STAT3 signaling in normal skin physiology. Furthermore, the interaction of STAT3 with PKC{delta} facilitates PKC{delta} function and is essential for insulin-induced proliferation of skin keratinocytes. Future studies will be aimed at understanding the mechanisms that underlie the specificity of the signal induced by STAT3 serine phosphorylation versus tyrosine phosphorylation in keratinocyte physiology and the pathology of skin cancer.


   Materials and Methods
Top
 Summary
 Introduction
 Results
 Discussion
 Materials and Methods
References
 
Reagents and antibodies
Tissue culture media and serum were purchased from Biological Industries (Beit HaEmek, Israel). Enhanced chemical luminescence (ECL) was performed with a SuperSignal West Pico Chemiluminescent Substrate Kit purchased from Pierce. Monoclonal anti p-Tyr antibody was purchased from Upstate Biotechnology (Lake Placid, NY). Polyclonal antibodies to PKC isoforms, polyclonal anti-STAT3, were purchased from Santa Cruz Biotechnology (CA). Monoclonal antibodies to PKC isoforms and STAT3 were purchased from Transduction Laboratories (Lexington, KY). Antibodies against STAT3, anti-phospho-tyrosine-705-STAT3 and anti-phospho-serine-727-STAT3 were purchased from Cell Signaling Technology (Beverly, MA). Horseradish-peroxidase-labeled anti-rabbit and anti-mouse IgG were obtained from Bio-Rad. Leupeptin, aprotinin, PMSF, ß-mercaptoethanol, orthovanadate, and pepstatin were purchased from Sigma Chemicals (St. Louis, MO). Insulin (HumulinR-recombinant human insulin) was purchased from Lilly France (Fergersheim, France). The PKC delta inhibitor, rottlerin, was purchased from Calbiochem.

Isolation and culture of murine keratinocytes
Primary keratinocytes were isolated as described from newborn BALB/C mice (Dlugosz et al., 1995Go). Keratinocytes were cultured in Eagle's minimal essential medium (EMEM) containing 8% fetal bovine serum pretreated with Chelex-100 (BioRad). To maintain a proliferative basal cell phenotype, the final Ca2+ concentration was adjusted to 0.05 mM. Serum starvation was induced by maintaining keratinocytes in medium containing 0.05% serum for 24 hours. Experiments were performed 5-7 days after plating.

Total cell extracts and western blots
Whole-cell lysates were prepared by scraping cells on ice into 300 µl lysis buffer containing 5% SDS, 20% 2-ß-mercaptoethanol and 50% western upper gel buffer (0.5 M Tris-HCl, pH 6.8). Lysates were homogenized, boiled for 5 minutes, and centrifuged at 28,000 g for 20 minutes. Supernatant containing the total cell protein extracts was transferred to a fresh tube. Protein loading buffer was added to an equal volume of the total cell extracts, samples were boiled for 5 minutes and centrifuged. Supernatants were separated by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad). Specific protein bands were detected by immunoblotting using specific antibodies and visualized by enhanced chemiluminescence.

Preparation of cell extracts in RIPA buffer
For crude membrane fractions, cells were washed with cold PBS three times, resuspended in RIPA buffer without SDS containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 1% deoxycholic acid, 1% Triton X-100, 0.25 mM EDTA (pH 8.0), and protease and phosphatase inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 2 µg/ml pepstatin A, 1 mM phenylmethylsulfonyl fluoride, 200 µM NaVO4 and 5 mM NaF). Lysates were incubated for 30 minutes at 4°C on ice and centrifuged at 4°C for 30 minutes at 28,000 g. The supernatant containing the soluble protein fraction (cytoplasmic and membrane) was transferred to another tube and used for immunoprecipitation. Protein concentrations were measured using a modified Lowry assay (Bio-Rad DC Protein Assay Kit). Western blot analysis of cellular protein fractions was carried out as described (Li et al., 1996aGo).

Immunoprecipitation and western blot analysis
Protein cell lysates, prepared in RIPA buffer, were precleared by mixing 0.3 ml cell lysate with 25 µl of Protein A/G Sepharose (Santa Cruz Biotechnology), and the suspension was rotated continuously for 30 minutes at 4°C. The preparation was then centrifuged at maximal speed at 4°C for 10 minutes. Supernatants were incubated with specific polyclonal or monoclonal antibodies to the individual PKC isoforms (diluted 1:100), anti-STAT3, anti-phosphotyrosine-STAT3, or anti-phosphoserine-STAT3 antibodies overnight at 4°C followed by incubation with protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) for 2 hours. The suspension was then centrifuged at maximal speed for 10 minutes at 4°C, the pellet was washed twice with RIPA buffer, twice with cold PBS and subjected to western blot analysis. Immunoprecipitates were separated by SDS-PAGE, transferred to nitrocellulose membrane (0.2 µm) (BIO-RAD) and blotted with specific polyclonal or monoclonal antibodies.

Experiments were repeated several times, as indicated in the figure legends, and blots of repeated experiments were analyzed by densitometry. Arbitrary units were normalized to a similar scale for all original figures maintaining the differential quantitative responses. Statistical analysis (mean ± s.d.) was performed accordingly.

Recombinant adenovirus constructs
The recombinant adenovirus vectors were constructed as described (Miyake et al., 1996Go). A dominant-negative mutant of mouse PKC{delta} was generated by substitution of the lysine residue at the ATP-binding site with alanine (Ohba et al., 1998Go). Adenoviral vectors containing the genes for HA-tagged STAT3 and HA-tagged DN STAT3 (AxCASTAT3 and AxCAdnSTAT3), which contained a CAG promoter (chicken ß-actin promoter with cytomegalovirus enhancer), were prepared by homologous recombination in HEK293 cells by using pAxCA 1w cosmid cassette, as described previously (Miyake et al., 1996Go). The dominant-negative activity of STAT3F gene was demonstrated by the abrogation of its tyrosine phosphorylation. A serine phosphorylation STAT3 mutant adenovirus was generated by the COS-TPC method using cosmids and recombinant adenoviruses containing pEFHA-Stat3-S727A expression vector (Miyake et al., 1996Go). PEFHA-Stat3S-727A was prepared by introducing a point mutation at Ser727 to Ala (Abe et al., 2001aGo). Viral titer was adjusted by the TCID50 method according to the manufacturer's protocol (Takara Shuzo, Japan) (Miyake et al., 1996Go). Briefly, a virus solution from HEK293 cell lysates was serially diluted into 96-well collagen-coated plates. A row of uninfected cells was used as controls. Complete cytopathic effect was judged by microscopic evaluation after 11-13 days of infection. Wells in which the virus induced a full cytopathic effect were counted and the 50% tissue culture infectious dose was calculated (TCID50) in correlation with the number of plaque-forming units. More than 95% of keratinocytes in the culture dish expressed the transduced protein following recombinant adenovirus infection as analyzed by ß-galactosidase adenovirus infection.

Overexpression of specific proteins by using of the recombinant adenovirus vectors
The culture medium was aspirated and keratinocyte cultures were infected with the viral supernatant containing PKC{delta}, DN PKC{delta}, WT STAT3 or DN STAT3 recombinant adenoviruses at an multiplicity of infection (MOI) of 12 for 1 hour. The cultures were then washed twice with PBS and re-fed low-Ca2+ MEM (0.05 mM) for 24 hours. ß-Galactosidase adenovirus was used as a negative control to exclude possible deleterious effects of the vector itself. Following infection, cells were incubated for 24 hours, and then were left untreated or treated with insulin, and used for proliferation assays, activity assays, immunocytochemistry assays or for immunoprecipitation and western blotting.

PKC activity
Specific PKC activity was determined in freshly prepared immunoprecipitates from keratinocyte cultures following appropriate treatments. These lysates were prepared in RIPA buffer without NaF. Activity was measured with use of the SignaTECT Protein Kinase C Assay System (Promega, Madison, WI) according to the manufacturer's instructions. Neurogranin (AAKIQAS*FRGHMARKK) was used as the substrate for PKC activity in these studies.

Cell proliferation
Cell proliferation was measured by [3H]thymidine incorporation in six-well plates. Cells were pulsed with [3H]thymidine (1 µCi/ml) for 1 hour. After incubation, cells were washed five times with PBS, and 5% TCA was then added to each well for 1 hour. The solution was removed and cells were solubilized in 1 M NaOH. The labeled thymidine incorporated into cells was counted in the 3H window of a Tricarb liquid scintillation counter.

Immunofluorescence
Primary keratinocytes were plated on ProbeOn Plus glass slides. Keratinocytes after 5 days of culture were left untreated or treated with insulin for 5 minutes and 30 minutes with or without pre-treatment with rottlerin for 7 minutes, infected either with PKC{delta}, DN PKC{delta}, or DN STAT3 adenoviruses for 1 hour, washed twice with Ca2+- and Mg2+-free PBS and maintained in culture in 0.05 mM Ca2+ EMEM. After infection, keratinocytes were incubated for 24 hours, then fixed in methanol for 10 minutes followed by permeabilization with 0.2% Triton X-100 for 5 minutes, rinsed with PBS and incubated for 18 hours at 4°C, with specific anti-PKC, anti-phosphotyrosine STAT3 or anti-STAT3-phosphoserine antibodies diluted in 1% BSA in PBS. After incubation, slides were washed twice for 10 minutes with PBS and incubated with biotinylated secondary anti-rabbit antibody for 40 minutes, washed twice in PBS and incubated with streptavidin-FITC for 40 minutes. Following two washes in PBS and one wash with double-distilled water, slides were air dried and mounted with Vectashield mounting medium (Vector). Fluorescence was examined by laser scanning confocal imaging microscopy (MRC1024, Bio-Rad, UK).


   Acknowledgments
 
This study was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science (MOS). Research was supported in part by the Israel Science Foundation (grant No. 4801).


   References
Top
 Summary
 Introduction
 Results
 Discussion
 Materials and Methods
 References
 

Abe, K., Hirai, M., Mizuno, K., Higashi, N., Sekimoto, T., Miki, T., Hirano, T. and Nakajima, K. (2001a). The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway. Oncogene 20, 3464-3474.[CrossRef][Medline]

Abe, K., Mizuno, K. and Nakajima, K. (2001b). No involvement of Erk/MAP kinases in IL-6-induced proliferation of a B cell hybridoma cell line. Osaka City Med. J. 47, 63-72.[Medline]

Akira, S. (1999). Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17, 138-146.[Abstract/Free Full Text]

Akira, S. (2000). Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19, 2607-2611.[CrossRef][Medline]

Alt, A., Ohba, M., Li, L., Gartsbein, M., Belanger, A., Denning, M. F., Kuroki, T., Yuspa, S. H. and Tennenbaum, T. (2001). Protein kinase Cdelta-mediated phosphorylation of alpha6beta4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment. Cancer Res. 61, 4591-4598.[Abstract/Free Full Text]

Alt, A., Gartsbein, M., Ohba, M., Kuroki, T. and Tennenbaum, T. (2004). Differential regulation of alpha6beta4 integrin by PKC isoforms in murine skin keratinocytes. Biochem. Biophys. Res. Commun. 314, 17-23.[CrossRef][Medline]

Boulton, T. G., Zhong, Z., Wen, Z., Darnell, J. E. J., Stahl, N. and Yancopoulos, G. D. (1995). STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92, 6915-6919.[Abstract/Free Full Text]

Bromberg, J. and Darnell, J. E. J. (2000). The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.[CrossRef][Medline]

Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W. and Darnell, J. E. J. (1998). Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.[Abstract/Free Full Text]

Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C. and Darnell, J. E. J. (1999). Stat3 as an oncogene Cell 98, 295-303. [erratum Cell 99, 239].[CrossRef][Medline]

Buchner, K. (2000). The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J. Cancer Res. Clin. Oncol. 126, 1-11.[CrossRef][Medline]

Calo, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N. and Russo, A. (2003). STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell Physiol. 197, 157-168.[CrossRef][Medline]

Ceresa, B. P. and Pessin, J. E. (1996). Insulin stimulates the serine phosphorylation of the signal transducer and activator of transcription (STAT3) isoform. J. Biol. Chem. 271, 12121-12124.[Abstract/Free Full Text]

Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S. and DiGiovanni, J. (2004). Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 64, 2382-2389.[Abstract/Free Full Text]

Chatterjee-Kishore, M., van den Akker, F. and Stark, G. R. (2000). Association of STATs with relatives and friends. Trends. Cell Biol. 10, 106-111.[CrossRef][Medline]

Chen, J. D., Lapiere, J. C., Sauder, D. N., Peavey, C. and Woodley, D. T. (1995). Interleukin-1{alpha} stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-{alpha}-independent pathway. J. Invest. Dermatol. 104, 729-733.[CrossRef][Medline]

Chung, J., Uchida, E., Grammer, T. C. and Blenis, J. (1997). STAT3 serine phosphorylation by ERK-dependent and –independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17, 6508-6516.[Abstract]

Darnell, J. E. J., Kerr, I. M. and Stark, G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.[Abstract/Free Full Text]

Decker, T. and Kovarik, P. (2000). Serine phosphorylation of STATs. Oncogene 19, 2628-2637.[CrossRef][Medline]

Dekker, L. V. and Parker, P. J. (1994). Protein kinase C – a question of specificity. Trends. Biochem. Sci. 19, 73-77.[CrossRef][Medline]

Denning, M. F., Dlugosz, A. A., Threadgill, D. W., Magnuson, T. and Yuspa, S. H. (1996). Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C {delta}. J. Biol. Chem. 271, 5325-5331.[Abstract/Free Full Text]

Dlugosz, A. A., Strickland, J. E., Pettit, G. R. and Yuspa, S. H. (1992). The role of protein kinase C in epidermal differentiation and neoplasia. In The Environmental Threat to the Skin (ed. R. Marks and G. Plewig), pp. 309-312. London: Martin Dunitz.

Dlugosz, A. A., Glick, A. B., Tennenbaum, T., Weinberg, W. C. and Yuspa, S. H. (1995). Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol. 254, 3-20.[Medline]

Dotto, P. (1998). The keratinocyte growth-differentiation switch. Front. Biosci. 3, d502-d508.[Medline]

Frank, D. A. (1999). STAT signaling in the pathogenesis and treatment of cancer. Mol. Med. 5, 432-456.[Medline]

Fujii, T., Garcia-Bermejo, M. L., Bernabo, J. L., Caamano, J., Ohba, M., Kuroki, T., Li, L., Yuspa, S. H. and Kazanietz, M. G. (2000). Involvement of protein kinase c delta (pkcdelta) in phorbol ester-induced apoptosis in lncap prostate cancer cells. lack of proteolytic cleavage of pkcdelta. J. Biol. Chem. 275, 7574-7582.[Abstract/Free Full Text]

Geiges, D., Marks, F. and Gschwendt, M. (1995). Loss of protein kinase C delta from human HaCaT keratinocytes upon ras transfection is mediated by TGF alpha. Exp. Cell Res. 219, 299-303.[CrossRef][Medline]

Gliki, G., Abu-Ghazaleh, R., Jezequel, S., Wheeler-Jones, C. and Zachary, I. (2001). Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-delta and by mobilization of intracellular Ca2+. Biochem. J. 353, 503-512.[CrossRef][Medline]

Goodnight, J. A., Mischak, H., Kolch, W. and Mushinski, J. F. (1995). Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes. J. Biol. Chem. 270, 9991-10001.[Abstract/Free Full Text]

Gotoh, A., Takahira, H., Mantel, C., Litz-Jackson, S., Boswell, H. S. and Broxmeyer, H. E. (1996). Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 88, 138-145.[Abstract/Free Full Text]

Hashimoto, K. (2000). Regulation of keratinocyte function by growth factors. J. Dermatol. Sci. 24, S46-S50.[CrossRef][Medline]

Heim, M. H. (1999). The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J. Recept. Signal. Transduct. Res. 19, 75-120.[Medline]

Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. and Graeve, L. (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314.[Medline]

Horvath, C. M. (2000). STAT proteins and transcriptional responses to extracellular signals. Trends. Biochem. Sci. 25, 496-502.[CrossRef][Medline]

Imada, K. and Leonard, W. J. (2000). The Jak-STAT pathway. Mol. Immunol. 37, 1-11.[CrossRef][Medline]

Jackson, T. A., Schweppe, R. E., Koterwas, D. M. and Bradford, A. P. (2001). Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta. Mol. Endocrinol. 15, 1517-1528.[Abstract/Free Full Text]

Jain, N., Zhang, T., Fong, S. L., Lim, C. P. and Cao, X. (1998). Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 17, 3157-3167.[CrossRef][Medline]

Jain, N., Zhang, T., Kee, W. H., Li, W. and Cao, X. (1999). Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J. Biol. Chem. 274, 24392-24400.[Abstract/Free Full Text]

Joseloff, E., Cataisson, C., Aamodt, H., Ocheni, H., Blumberg, P., Kraker, A. J. and Yuspa, S. H. (2002). Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J. Biol. Chem. 277, 12318-12323.[Abstract/Free Full Text]

Kim, Y. B., Uotani, S., Pierroz, D., Flier, J. and Kahn, B. (2000). In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141, 2328-2339.[Abstract/Free Full Text]

Kontny, E., Ziolkowska, M., Ryzewska, A. and Maslinski, W. (1999). Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). Cytokine 11, 839-848.[CrossRef][Medline]

Kovarik, P., Stoiber, D., Eyers, P. A., Menghini, R., Neininger, A., Gaestel, M., Cohen, P. and Decker, T. (1999). Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 96, 13956-13961.[Abstract/Free Full Text]

Kuroki, M. and O'Flaherty, J. T. (1999). Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. Biochem. J. 341, 691-696.[CrossRef][Medline]

Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A. and Sampson, S. R. (2001). Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am. J. Clin. Pathol. 116, 377-385.[Abstract/Free Full Text]

Levy, D. E. and Darnell, J. E. J. (2002). Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3, 651-662.[CrossRef][Medline]

Li, L., Tennenbaum, T. and Yuspa, S. H. (1996a). Suspension-induced murine keratinocyte differentiation is mediated by calcium. J. Invest. Dermatol. 106, 254-260.[CrossRef][Medline]

Li, W., Michieli, P., Alimandi, M., Lorenzi, M. V., Wu, Y., Wang, L. H., Heidaran, M. A. and Pierce, J. H. (1996b). Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. Oncogene 13, 731-737.[Medline]

Li, L., Lorenzo, P. S., Bogi, K., Blumberg, P. M. and Yuspa, S. H. (1999). Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol. Cell. Biol. 19, 8547-8558.[Abstract/Free Full Text]

Lim, C. P. and Cao, X. (1999). Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 274, 31055-31061.[Abstract/Free Full Text]

Lucas, M. and Sanchez-Margalet, V. (1995). Protein kinase C involvement in apoptosis. Gen. Pharmacol. 26, 881-887.[Medline]

Ma, J., Zhang, T., Novotny-Diermayr, V., Tan, A. L. and Cao, X. (2003). A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation. J. Biol. Chem. 278, 29252-29260.[Abstract/Free Full Text]

Marchese, C., Rubin, J., Ron, D., Faggioni, A., Torrisi, M. R., Messina, A., Frati, L. and Aaronson, S. A. (1990). Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell. Physiol. 144, 326-332.[CrossRef][Medline]

Matsui, M. S., Chew, S. L. and DeLeo, V. A. (1992). Protein kinase C in normal human epidermal keratinocytes during proliferation and calcium-induced differentiation. J. Invest. Dermatol. 99, 565-571.[CrossRef][Medline]

Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C. and Saito, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93, 1320-1324.[Abstract/Free Full Text]

Novotny-Diermayr, V., Zhang, T., Gu, L. and Cao, X. (2002). Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction. J. Biol. Chem. 277, 49134-49142.[Abstract/Free Full Text]

Ohba, M., Ishino, K., Kashiwagi, M., Kawabe, S., Chida, K., Huh, N. H. and Kuroki, T. (1998). Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. Mol. Cell. Biol. 18, 5199-5207.[Abstract/Free Full Text]

Pranada, A. L., Metz, S., Herrmann, A., Heinrich, P. C. and Muller-Newen, G. (2004). Real time analysis of STAT3 nucleocytoplasmic shuttling. J. Biol. Chem. 279, 15114-15123.[Abstract/Free Full Text]

Robin, P., Boulven, I., Bole-Feysot, C., Tanfin, Z. and Leiber, D. (2004). Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Am. J. Physiol. Cell Physiol. 286, C798-C806.[Abstract/Free Full Text]

Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S. and Takeda, J. (1999). Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18, 4657-4668.[CrossRef][Medline]

Sano, S., Kira, M., Takagi, S., Yoshikawa, K., Takeda, J. and Itami, S. (2000). Two distinct signaling pathways in hair cycle induction: Stat3-dependent and –independent pathways. Proc. Natl. Acad. Sci. USA 97, 13824-13829.[Abstract/Free Full Text]

Schuringa, J. J., Dekker, L. V., Vellenga, E. and Kruijer, W. (2001). Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J. Biol. Chem. 276, 27709-27715.[Abstract/Free Full Text]

Senaldi, G., Varnum, B. C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C. L. et al. (1999). Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci. USA 96, 11458-11463.[Abstract/Free Full Text]

Sengupta, T. K., Talbot, E. S., Scherle, P. A. and Ivashkiv, L. B. (1998). Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 95, 11107-11112.[Abstract/Free Full Text]

Shen, S., Alt, A., Wertheimer, E., Gartsbein, M., Kuroki, T., Ohba, M., Braiman, L., Sampson, S. R. and Tennenbaum, T. (2001). PKCdelta activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes. Diabetes 50, 255-264.[Abstract/Free Full Text]

Shen, Y., Schlessinger, K., Zhu, X., Meffre, E., Quimby, F., Levy, D. E. and Darnell, J. E. J. (2004). Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24, 407-419.[Abstract/Free Full Text]

Silva, C. M. (2004). Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23, 8017-8023.[CrossRef][Medline]

Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T. and Akira, S. (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.[Abstract/Free Full Text]

Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S. (1998). Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161, 4652-4660.[Abstract/Free Full Text]

Toker, A. (1998). Signaling through protein kinase C. Front. Biosci. 3, D1134-D1147.[Medline]

Turkson, J. and Jove, R. (2000). STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-6626.[CrossRef][Medline]

Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., de Groot, R. P. and Jove, R. (1998). Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18, 2545-2552.[Abstract/Free Full Text]

Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S. et al. (1999). Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol. Cell. Biol. 19, 7519-7528.[Abstract/Free Full Text]

Verma, A. K. (1988). The protein kinace C activator L-dioctanoylglycerol: a potent stage II mouse skin tumor promoter. Cancer Res. 48, 1736-1739.[Abstract/Free Full Text]

Wen, Z. and Darnell, J. E. J. (1997). Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25, 2062-2067.[Abstract/Free Full Text]

Werner, S. and Smola, H. (2001). Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol. 11, 143-146.[CrossRef][Medline]

Wertheimer, E., Spravchikov, N., Trebicz, M., Gartsbein, M., Accili, D., Avinoah, I., Nofeh-Moses, S., Sizyakov, G. and Tennenbaum, T. (2001). The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 142, 1234-1241.[Abstract/Free Full Text]

Xu, B., Bhattacharjee, A., Roy, B., Xu, H. M., Anthony, D., Frank, D. A., Feldman, G. M. and Cathcart, M. K. (2003). Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol. Cell. Biol. 23, 3918-3928.[Abstract/Free Full Text]

Xu, J., Ji, S., Venable, D., Franklin, J. and Messina, J. (2005). Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1. J. Endocrinol. 184, 481-492.[Abstract/Free Full Text]

Zendegui, J. G., Inman, W. H. and Carpenter, G. (1988). Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta. J. Cell Physiol. 136, 257-265.[CrossRef][Medline]

Zhang, T., Kee, W. H., Seow, K. T., Fung, W. and Cao, X. (2000). The coiled-coil domain of Stat3 is essential for its SH2 domain-mediated receptor binding and subsequent activation induced by epidermal growth factor and interleukin-6. Mol. Cell. Biol. 20, 7132-7139.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. L. Schwartz, R. Malgor, E. Dickerson, A. T. Weeraratna, A. Slominski, J. Wortsman, N. Harii, A. D. Kohn, R. T. Moon, F. L. Schwartz, et al.
Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration
Clin. Cancer Res., June 15, 2009; 15(12): 4114 - 4122.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Saleh, L. Shan, A. J. Halayko, S. Kung, and A. S. Gounni
Critical Role for STAT3 in IL-17A-Mediated CCL11 Expression in Human Airway Smooth Muscle Cells
J. Immunol., March 15, 2009; 182(6): 3357 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Sud, S. Kumar, S. Wedgwood, and S. M. Black
Modulation of PKC{delta} signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L519 - L526.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Dissanayake, P. B. Olkhanud, M. P. O'Connell, A. Carter, A. D. French, T. C. Camilli, C. D. Emeche, K. J. Hewitt, D. T. Rosenthal, P. D. Leotlela, et al.
Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation
Cancer Res., December 15, 2008; 68(24): 10205 - 10214.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Oyasu, M. Fujimiya, K. Kashiwagi, S. Ohmori, H. Imaeda, and N. Saito
Immunogold Electron Microscopic Demonstration of Distinct Submembranous Localization of the Activated {gamma}PKC Depending on the Stimulation
J. Histochem. Cytochem., March 1, 2008; 56(3): 253 - 265.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. D. McCall, N. Harii, C. J. Lewis, R. Malgor, W. Bae Kim, M. Saji, A. D. Kohn, R. T. Moon, and L. D. Kohn
High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration
Endocrinology, September 1, 2007; 148(9): 4226 - 4237.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.02744v1
119/3/470    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gartsbein, M.
Right arrow Articles by Tennenbaum, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gartsbein, M.
Right arrow Articles by Tennenbaum, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?